Edition:
United Kingdom

Rite Aid Corp (RAD.N)

RAD.N on New York Stock Exchange

1.82USD
7:24pm BST
Change (% chg)

$0.05 (+3.12%)
Prev Close
$1.76
Open
$1.77
Day's High
$1.84
Day's Low
$1.75
Volume
908,642
Avg. Vol
2,932,910
52-wk High
$2.80
52-wk Low
$1.38

Chart for

About

Rite Aid Corporation is a retail drugstore chain. The Company's segments include Retail Pharmacy and Pharmacy Services. The Company operates under The Rite Aid name. It operates approximately 4,560 stores in over 30 states across the country and in the District of Columbia. The Company's Retail Pharmacy segment consists of Rite... (more)

Overall

Beta: 1.79
Market Cap(Mil.): $2,085.36
Shares Outstanding(Mil.): 1,063.96
Dividend: --
Yield (%): --

Financials

  RAD.N Industry Sector
P/E (TTM): 23.93 20.98 40.76
EPS (TTM): 0.08 -- --
ROI: 1.05 11.71 62.30
ROE: 13.22 13.91 73.91

U.S. jury fails to reach verdict in latest J&J talc trial

NEW YORK A South Carolina jury on Friday could not agree on a verdict in a case of a woman whose family said her long-term use of Johnson & Johnson's Baby Powder led to her death from asbestos-related cancer, resulting in a mistrial.

26 May 2018

UPDATE 1-U.S. jury fails to reach verdict in latest J&J talc trial

NEW YORK, May 25 A South Carolina jury on Friday could not agree on a verdict in a case of a woman whose family said her long-term use of Johnson & Johnson's Baby Powder led to her death from asbestos-related cancer, resulting in a mistrial.

26 May 2018

U.S. jury fails to reach verdict in latest J&J talc trial over asbestos claims

NEW YORK, May 25 A South Carolina jury on Friday could not agree on a verdict in a case of a woman whose family said her long-term use of Johnson & Johnson's Baby Powder led to her death from asbestos-related cancer, resulting in a mistrial.

25 May 2018

BRIEF-Rite Aid Announces Results Of Offer To Purchase Certain Of Its Outstanding Series Of Notes

* RITE AID ANNOUNCES RESULTS OF OFFER TO PURCHASE CERTAIN OF ITS OUTSTANDING SERIES OF NOTES

22 May 2018

BRIEF-Rite Aid Entered Second Amended & Restated Debt Commitment Letter

* RITE AID - ON MAY 8 ENTERED SECOND AMENDED & RESTATED DEBT COMMITMENT LETTER TO GIVE CO $4.67 BILLION OF COMMITMENTS TO $5 BILLION BEST EFFORTS ABL FACILITY

09 May 2018

UPDATE 1-Fred's Inc CEO Michael Bloom steps down

April 27 Fred's Inc, which was forced to abandon its bid to acquire certain stores of drug retailer Rite Aid Corp, said on Friday its Chief Executive Officer Michael Bloom has resigned.

27 Apr 2018

BRIEF-Rite Aid Commences Offer To Purchase Certain Of Its Outstanding Series Of Notes

* RITE AID COMMENCES OFFER TO PURCHASE CERTAIN OF ITS OUTSTANDING SERIES OF NOTES

19 Apr 2018

BRIEF-Naloxone Available At Rite Aid Pharmacies In 19 U.S. States

* RITE AID - NALOXONE, A MEDICATION THAT CAN BE USED TO REVERSE EFFECTS OF OPIOID OVERDOSE, IS AVAILABLE AT EACH OF MORE THAN 2,500 U.S. RITE AID PHARMACIES

19 Apr 2018

Drug retailer Rite Aid's upbeat forecast lifts shares

Drug retailer Rite Aid Corp on Thursday forecast a full-year profit largely above estimates as it expects reimbursement rates to rise this year and its deal with Walgreens to help it secure better generic drug prices.

12 Apr 2018

UPDATE 2-Drug retailer Rite Aid's upbeat forecast lifts shares

* Shares up 3 pct at $1.68 (Recasts, adds details and analyst comment, updates shares)

12 Apr 2018

Competitors

  Price Chg
Walmart Inc (WMT.N) $88.04 -0.03
CVS Health Corp (CVS.N) $66.41 -1.49
AmerisourceBergen Corp. (ABC.N) $86.27 -0.06

Earnings vs. Estimates